A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer(University of North Carolina at Chapel Hill), J. E. Wraith(Manchester University NHS Foundation Trust), Michael Beck(Johannes Gutenberg University Mainz), Roberto Giugliani(Universidade Federal do Rio Grande do Sul), Paul Harmatz(Developmental Studies Center), Christine M. Eng(Baylor College of Medicine), Ashok Vellodi(Great Ormond Street Hospital), Rick Martin(St. Louis Children's Hospital), Uma Ramaswami(University of Cambridge), Müge Güçsavaş‐Çalıkoğlu(University of North Carolina at Chapel Hill), Suresh Vijayaraghavan(Manchester University NHS Foundation Trust), S. Wendt(Johannes Gutenberg University Mainz), Antonio Puga(Universidade Federal do Rio Grande do Sul), B. Ulbrich(University of Cambridge), Marwan Shinawi(Baylor College of Medicine), Maureen Cleary(Great Ormond Street Hospital), Diane Piper(Takeda (United States)), Ann Marie Conway(Takeda (United States)), Alan Kimura(Takeda (United States))
Cited by 583Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis